These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 38374141)

  • 1. Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review.
    Hu S; Hang X; Wei Y; Wang H; Zhang L; Zhao L
    Cell Commun Signal; 2024 Feb; 22(1):136. PubMed ID: 38374141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
    Fu J; Lee K; Chuang PY; Liu Z; He JC
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease.
    Jiang S; Su H
    Cell Commun Signal; 2023 Oct; 21(1):288. PubMed ID: 37845726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes.
    Casalena GA; Yu L; Gil R; Rodriguez S; Sosa S; Janssen W; Azeloglu EU; Leventhal JS; Daehn IS
    Cell Commun Signal; 2020 Jul; 18(1):105. PubMed ID: 32641054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.
    Jiang S; Luo M; Bai X; Nie P; Zhu Y; Cai H; Li B; Luo P
    J Cell Commun Signal; 2022 Sep; 16(3):313-331. PubMed ID: 35041192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
    Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
    J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
    Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
    Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
    Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
    Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cellular crosstalk in the progression of diabetic nephropathy.
    Zhang K; Fu Z; Zhang Y; Chen X; Cai G; Hong Q
    Front Endocrinol (Lausanne); 2023; 14():1173933. PubMed ID: 37538798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the mesangium in glomerular function.
    Boi R; Ebefors K; Nyström J
    Acta Physiol (Oxf); 2023 Oct; 239(2):e14045. PubMed ID: 37658606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
    Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
    Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
    Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
    Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietins and diabetic nephropathy.
    Gnudi L
    Diabetologia; 2016 Aug; 59(8):1616-20. PubMed ID: 27207083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease.
    Chen SJ; Lv LL; Liu BC; Tang RN
    Cell Prolif; 2020 Mar; 53(3):e12763. PubMed ID: 31925859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
    Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
    Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease.
    Petrazzuolo A; Sabiu G; Assi E; Maestroni A; Pastore I; Lunati ME; Montefusco L; Loretelli C; Rossi G; Ben Nasr M; Usuelli V; Xie Y; Balasubramanian HB; Zocchi M; El Essawy B; Yang J; D'Addio F; Fiorina P
    Pharmacol Res; 2023 Apr; 190():106710. PubMed ID: 36871895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.